[33, 34, 35, 36] Mechanism: Typically pre-renal, occurring in the setting of volume depletion from GI losses (nausea, vomiting, diarrhea, reduced oral intake) More frequently seen at higher, obesity-level doses Although generally reno-protective long term, post-marketing data describe acute rises in creatinine following days to weeks of significant GI symptoms Risk factors: Underlying chronic kidney disease Concomitant use of ACE inhibitors, ARBs, diuretics, or SGLT2 inhibitors ED Management: IV fluids Hold GLP-1 and contributing medications Usually reversible with supportive care Future Directions GLP-1 receptor agonists are rapidly evolving beyond their original indications in diabetes and obesity
For trips longer than a few days, ask PlexusDx about pharmacy locations along your route where you can store your medication properly
Mochi health (the compounding specialist) Mochi is a favorite in the 2026 GLP-1 community because they offer a flat monthly rate that includes medication regardless of the dose
This sequence is associated with the production of several cytokines that cause liver fibrosis [8]